2-dimethylamino-5-trifluoromethyl-benzaldehyde | 945847-58-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-dimethylamino-5-trifluoromethyl-benzaldehyde
• 英文别名: 2-(Dimethylamino)-5-(trifluoromethyl)benzaldehyde；2-(dimethylamino)-5-(trifluoromethyl)benzaldehyde
• CAS: 945847-58-5
• 化学式: C₁₀H₁₀F₃NO
• 分子量: 217.191
• InChiKey: YWWATSPMFRZORV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  20.3
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  2-dimethylamino-5-trifluoromethyl-benzaldehyde 在 sodium tetrahydroborate 作用下， 以 乙醇 为溶剂， 反应 0.25h， 生成 [2-(Dimethylamino)-5-(trifluoromethyl)phenyl]methanol
  参考文献：
  名称：

  WO2007/88996

  摘要：

  公开号：
• 作为产物：
  描述：

  盐酸二甲胺 、 2-氟-5-(三氟甲基)苯甲醛 在 potassium carbonate 作用下， 以 甲苯 为溶剂， 生成 2-dimethylamino-5-trifluoromethyl-benzaldehyde
  参考文献：
  名称：

  WO2007/88996

  摘要：

  公开号：

文献信息

• Trisubstituted amine compound
  申请人：Nakamura Yoshinori

  公开号：US20090029994A1

  公开（公告）日：2009-01-29

  The present invention relates to a compound of the general formula (1): wherein, Y is a methylene group, and the like; A is an optionally substituted heterocyclic group, and the like; B is an optionally substituted phenyl group, and the like; R 1 is an optionally substituted alkyl group, and the like; and R 2 is an optionally substituted amino group, and the like; or a pharmaceutically acceptable derivative thereof, which has an inhibitory activity against cholesteryl ester transfer protein (CETP), thereby being useful for prophylaxis and/or treatment of arteriosclerotic diseases, hyperlipemia or dyslipidemia, and the like.

  本发明涉及一般式(1)的化合物，其中Y是亚甲基基团等；A是可选择取代的杂环基团等；B是可选择取代的苯基团等；R1是可选择取代的烷基团等；R2是可选择取代的氨基团等；或其药学上可接受的衍生物，该化合物具有胆固醇酯转移蛋白（CETP）的抑制活性，因此可用于动脉粥样硬化疾病、高脂血症或异常脂质血症的预防和/或治疗等。
• NOVEL CURCUMIN DERIVATIVE
  申请人：Takahashi Takashi

  公开号：US20100048901A1

  公开（公告）日：2010-02-25

  The present invention provides a novel compound that is structurally similar to curcumin and has a suppressive effect on Aβ aggregation, a degradative effect on Aβ aggregates, an inhibitory effect on β-secretase, and a protective effect on neurons. The novel compound is a compound represented by the following general formula (Ia) or a salt thereof: wherein R 1 represents a 4-hydroxy-3-methoxyphenyl group or the like, and R 2 represents a 1H-indol-6-yl group or the like.

  本发明提供了一种新型化合物，其结构类似于姜黄素，并具有抑制Aβ聚集、降解Aβ聚集体、抑制β-分泌酶以及保护神经元的作用。该新型化合物是由以下通式(Ia)或其盐所表示的化合物：其中，R1表示4-羟基-3-甲氧基苯基或类似基团，R2表示1H-吲哚-6-基基或类似基团。
• TRISUBSTITUTED AMINE COMPOUND
  申请人：NAKAMURA Yoshinori

  公开号：US20110092506A1

  公开（公告）日：2011-04-21

  The present invention relates to a compound of the general formula (1): wherein, Y is a methylene group, and the like; A is an optionally substituted heterocyclic group, and the like; B is an optionally substituted phenyl group, and the like; R 1 is an optionally substituted alkyl group, and the like; and R 2 is an optionally substituted amino group, and the like; or a pharmaceutically acceptable derivative thereof, which has an inhibitory activity against cholesteryl ester transfer protein (CETP), thereby being useful for prophylaxis and/or treatment of arteriosclerotic diseases, hyperlipemia or dyslipidemia, and the like.

  本发明涉及一种通式（1）的化合物：其中，Y是亚甲基基团等；A是可选取的取代杂环基团等；B是可选取的取代苯基团等；R1是可选取的取代烷基团等；R2是可选取的取代氨基团等；或其药学上可接受的衍生物。该化合物具有对胆固醇酯转移蛋白（CETP）的抑制活性，因此可用于预防和/或治疗动脉硬化性疾病、高脂血症或血脂异常等。
• Divergent synthesis of nitrogen heterocycles<i>via</i>H₂O-mediated hydride transfer reactions
  作者：Fangzhi Hu、Zhipeng Sun、Mengzhe Pan、Liang Wang、Lubin Xu、Xiong-Li Liu、Shuai-Shuai Li

  DOI：10.1039/d3gc00166k

  日期：——

  of diverse nitrogen heterocycles from readily available feedstocks was developed by a hydride transfer strategy. A variety of 3-carboxyl and 3-acyl substituted tetrahydroquinolines and 3,4-dihydroquinolin-2(1H)-ones were obtained via cascade Knoevenagel condensation/[1,5]-hydride transfer/cyclization/hydrolysis/decarboxylation and cascade Knoevenagel condensation/[1,5]-hydride transfer/N-dealkylation/N-acylation

  通过氢化物转移策略开发了H 2 O 促进的多种氮杂环化合物从现成原料的可控合成。通过级联Knoevenagel缩合/[ 1,5 ]-氢化物转移/环化/水解/脱羧和级联Knoevenagel获得了多种3-羧基和3-酰基取代的四氢喹啉和3,4-二氢喹啉-2(1 H) -ones分别为缩合/[1,5]-氢化物转移/ N-脱烷基化/ N-酰化过程。此外，还很好地介绍了方法学和机理研究的综合效用。
• TRISUBSTITUTED AMINE COMPOUNDS AS INHIBITORS OF -CHOLESTERYL ESTER TRANSFER PROTEIN CETP
  申请人：Mitsubishi Tanabe Pharma Corporation

  公开号：EP1979331A1

  公开（公告）日：2008-10-15